TAUNS Laboratories,Inc. (TYO:197A)

TAUNS Laboratories,Inc. Income Statement

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023
Revenue	14,577	18,628	18,435	15,673
Revenue Growth (YoY)	-7.00%	1.05%	17.62%	-
Cost of Revenue	4,983	5,853	5,937	6,473
Gross Profit	9,594	12,775	12,498	9,200
Selling, General & Admin	4,078	4,061	4,045	3,819
Operating Expenses	4,527	4,510	4,468	4,233
Operating Income	5,067	8,265	8,030	4,967
Interest Expense	-137.88	-102.9	-31.21	-21.81
Interest & Investment Income	21.22	14.15	7.69	7.47
Other Non Operating Income (Expenses)	20.76	43.68	-165.95	0.51
EBT Excluding Unusual Items	4,971	8,220	7,841	4,953
Gain (Loss) on Sale of Investments	-	-	-1.67	-297.85
Gain (Loss) on Sale of Assets	-18.68	-18.09	-6.16	-0.74
Other Unusual Items	0	0	1.89	-
Pretax Income	4,953	8,202	7,835	4,655
Income Tax Expense	976.15	1,886	2,061	1,620
Net Income	3,977	6,315	5,774	3,035
Net Income to Common	3,977	6,315	5,774	3,035
Net Income Growth	31.03%	9.38%	90.26%	-
Shares Outstanding (Basic)	102	102	100	100
Shares Outstanding (Diluted)	107	107	107	100
Shares Change (YoY)	7.33%	0.26%	6.94%	-
EPS (Basic)	38.83	62.07	57.74	30.35
EPS (Diluted)	37.05	58.90	53.99	30.35
EPS Growth	22.07%	9.09%	77.90%	-
Free Cash Flow	-	2,137	6,182	-4,247
Free Cash Flow Per Share	-	19.94	57.80	-42.47
Dividend Per Share	18.000	18.000	10.650	-
Dividend Growth	-	69.01%	-	-
Gross Margin	65.82%	68.58%	67.80%	58.70%
Operating Margin	34.76%	44.37%	43.56%	31.69%
Profit Margin	27.28%	33.90%	31.32%	19.36%
Free Cash Flow Margin	-	11.47%	33.53%	-27.10%
EBITDA	5,793	8,980	8,706	5,607
EBITDA Margin	39.74%	48.21%	47.23%	35.78%
D&A For EBITDA	725.24	715.43	676.16	639.97
EBIT	5,067	8,265	8,030	4,967
EBIT Margin	34.76%	44.37%	43.56%	31.69%
Effective Tax Rate	19.71%	23.00%	26.30%	34.80%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.